| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 18 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 13 |
| NetGPI | no | yes: 0, no: 13 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0005856 | cytoskeleton | 5 | 1 |
| GO:0005930 | axoneme | 2 | 1 |
| GO:0043226 | organelle | 2 | 1 |
| GO:0043228 | non-membrane-bounded organelle | 3 | 1 |
| GO:0043229 | intracellular organelle | 3 | 1 |
| GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 1 |
| GO:0110165 | cellular anatomical entity | 1 | 2 |
| GO:0016020 | membrane | 2 | 1 |
Related structures:
AlphaFold database: E9AX44
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0000226 | microtubule cytoskeleton organization | 3 | 1 |
| GO:0006996 | organelle organization | 4 | 1 |
| GO:0007010 | cytoskeleton organization | 5 | 1 |
| GO:0007017 | microtubule-based process | 2 | 1 |
| GO:0009987 | cellular process | 1 | 1 |
| GO:0016043 | cellular component organization | 3 | 1 |
| GO:0034453 | microtubule anchoring | 4 | 1 |
| GO:0071840 | cellular component organization or biogenesis | 2 | 1 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0005488 | binding | 1 | 2 |
| GO:0005515 | protein binding | 2 | 2 |
| GO:0008017 | microtubule binding | 5 | 2 |
| GO:0008092 | cytoskeletal protein binding | 3 | 2 |
| GO:0015631 | tubulin binding | 4 | 2 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 11 | 15 | PF00656 | 0.552 |
| CLV_NRD_NRD_1 | 129 | 131 | PF00675 | 0.640 |
| CLV_NRD_NRD_1 | 57 | 59 | PF00675 | 0.593 |
| CLV_PCSK_FUR_1 | 127 | 131 | PF00082 | 0.668 |
| CLV_PCSK_KEX2_1 | 129 | 131 | PF00082 | 0.641 |
| CLV_PCSK_PC1ET2_1 | 129 | 131 | PF00082 | 0.668 |
| CLV_PCSK_SKI1_1 | 167 | 171 | PF00082 | 0.642 |
| CLV_Separin_Metazoa | 151 | 155 | PF03568 | 0.633 |
| DOC_MAPK_MEF2A_6 | 248 | 256 | PF00069 | 0.683 |
| DOC_MAPK_MEF2A_6 | 27 | 35 | PF00069 | 0.574 |
| DOC_PP2B_LxvP_1 | 33 | 36 | PF13499 | 0.595 |
| DOC_USP7_MATH_1 | 92 | 96 | PF00917 | 0.566 |
| DOC_WW_Pin1_4 | 130 | 135 | PF00397 | 0.388 |
| LIG_14-3-3_CanoR_1 | 61 | 65 | PF00244 | 0.664 |
| LIG_BRCT_BRCA1_1 | 177 | 181 | PF00533 | 0.647 |
| LIG_EVH1_1 | 162 | 166 | PF00568 | 0.629 |
| LIG_EVH1_2 | 165 | 169 | PF00568 | 0.573 |
| LIG_FHA_2 | 40 | 46 | PF00498 | 0.529 |
| LIG_FHA_2 | 75 | 81 | PF00498 | 0.576 |
| LIG_LIR_Apic_2 | 222 | 228 | PF02991 | 0.535 |
| LIG_LIR_Apic_2 | 255 | 260 | PF02991 | 0.596 |
| LIG_LIR_Nem_3 | 178 | 184 | PF02991 | 0.645 |
| LIG_Pex14_1 | 121 | 125 | PF04695 | 0.668 |
| LIG_SH2_CRK | 225 | 229 | PF00017 | 0.570 |
| LIG_SH2_CRK | 257 | 261 | PF00017 | 0.576 |
| LIG_SH2_NCK_1 | 257 | 261 | PF00017 | 0.594 |
| LIG_SH2_STAP1 | 187 | 191 | PF00017 | 0.493 |
| LIG_SH2_STAT5 | 142 | 145 | PF00017 | 0.697 |
| LIG_SH2_STAT5 | 187 | 190 | PF00017 | 0.487 |
| LIG_SH2_STAT5 | 47 | 50 | PF00017 | 0.542 |
| LIG_SH3_3 | 133 | 139 | PF00018 | 0.628 |
| LIG_SH3_3 | 160 | 166 | PF00018 | 0.559 |
| LIG_SH3_3 | 239 | 245 | PF00018 | 0.607 |
| LIG_TRAF2_1 | 148 | 151 | PF00917 | 0.578 |
| LIG_TRAF2_1 | 77 | 80 | PF00917 | 0.575 |
| MOD_CDK_SPxxK_3 | 130 | 137 | PF00069 | 0.392 |
| MOD_CK1_1 | 6 | 12 | PF00069 | 0.589 |
| MOD_CK2_1 | 64 | 70 | PF00069 | 0.624 |
| MOD_CK2_1 | 74 | 80 | PF00069 | 0.505 |
| MOD_GlcNHglycan | 200 | 203 | PF01048 | 0.669 |
| MOD_GlcNHglycan | 221 | 224 | PF01048 | 0.546 |
| MOD_GlcNHglycan | 260 | 263 | PF01048 | 0.581 |
| MOD_GSK3_1 | 138 | 145 | PF00069 | 0.595 |
| MOD_GSK3_1 | 171 | 178 | PF00069 | 0.652 |
| MOD_GSK3_1 | 60 | 67 | PF00069 | 0.656 |
| MOD_N-GLC_1 | 125 | 130 | PF02516 | 0.671 |
| MOD_N-GLC_1 | 185 | 190 | PF02516 | 0.567 |
| MOD_NEK2_1 | 108 | 113 | PF00069 | 0.518 |
| MOD_NEK2_1 | 175 | 180 | PF00069 | 0.655 |
| MOD_NEK2_1 | 198 | 203 | PF00069 | 0.672 |
| MOD_NEK2_1 | 217 | 222 | PF00069 | 0.512 |
| MOD_NEK2_1 | 74 | 79 | PF00069 | 0.553 |
| MOD_NEK2_2 | 60 | 65 | PF00069 | 0.709 |
| MOD_PKA_2 | 60 | 66 | PF00069 | 0.640 |
| MOD_Plk_1 | 171 | 177 | PF00069 | 0.568 |
| MOD_Plk_1 | 39 | 45 | PF00069 | 0.528 |
| MOD_Plk_4 | 138 | 144 | PF00069 | 0.702 |
| MOD_Plk_4 | 252 | 258 | PF00069 | 0.600 |
| MOD_Plk_4 | 60 | 66 | PF00069 | 0.660 |
| MOD_ProDKin_1 | 130 | 136 | PF00069 | 0.525 |
| TRG_DiLeu_BaEn_1 | 80 | 85 | PF01217 | 0.673 |
| TRG_NLS_MonoExtN_4 | 56 | 62 | PF00514 | 0.624 |
| TRG_Pf-PMV_PEXEL_1 | 154 | 158 | PF00026 | 0.591 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1PAS5 | Leptomonas seymouri | 82% | 99% |
| A0A0S4J038 | Bodo saltans | 39% | 100% |
| A0A0S4J0F3 | Bodo saltans | 28% | 100% |
| A0A0S4JWV5 | Bodo saltans | 33% | 98% |
| A0A1X0NVY6 | Trypanosomatidae | 61% | 100% |
| A0A3R7MY93 | Trypanosoma rangeli | 61% | 100% |
| A0A3S7WYJ9 | Leishmania donovani | 96% | 100% |
| A4HDR0 | Leishmania braziliensis | 92% | 100% |
| A4I106 | Leishmania infantum | 96% | 100% |
| C9ZWA3 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 57% | 100% |
| Q4QAD2 | Leishmania major | 97% | 100% |
| V5BF29 | Trypanosoma cruzi | 60% | 89% |